At its Sept. 11-12, 2023 meeting, the Board approved several items, including a revised PCORI meetings and sessions policy and the amended PCORI Bylaws. The Board also approved new appointments to PCORI's five multi-stakeholder advisory panels.

In addition, the Board received the Executive Director's report and engaged in a strategy discussion about advancing PCORI's comparative clinical effectiveness research (CER) portfolio, among other business. View the agenda below for details.

Meeting Materials

Webinar Recordings

Approved Minutes of the Sept. 11 & 12, 2023 Board Meeting

Public Comment Period

This meeting included a public comment period on Tuesday, Sept. 12. Registration^ was required to provide comments via telephone. (Guidelines for Public Comments) (Technical Guidance for Commenters). However, there were no confirmed requests to provide comments by 5pm ET on the business day before the scheduled public comment period, so the public comment period was not initiated.

All PCORI Board meetings are open to the public. Members of the public were invited to join this two-day meeting via teleconference/webinar. Registration was required for each day of the meeting.

Catch up on past PCORI Board meetings here.

*The meeting agenda was subject to change. The meeting adjourned at 3:45 pm (ET).

^Please note that after you sign up to provide comment at this meeting, you will receive a confirmation email from PCORI about your registration. Please check your spam folder for this email if you don’t receive it, and reply to the email to confirm your intention to make a public comment.


Location Type